AI Generated PET/CT Images Cut Patient Radiation Exposure in Half

The CT portion of the exam contributes to a patient’s overall radiation exposure yet is largely redundant. Now, a novel artificial intelligence method can be used to generate high-quality PET/CT images and subsequently decrease radiation exposure to the patient.

Developed by the National Cancer Institute (NCI, Bethesda, MD, USA), the method bypasses the need for CT-based attenuation correction, potentially allowing for more frequent PET imaging to monitor disease and treatment progression without radiation exposure from CT acquisition. In their study, the researchers sought to reduce or eliminate the need for low-dose CT in PET/CT by using an artificial intelligence model to generate virtual attenuation-corrected PET scans.

The data cohort for the artificial intelligence model development included 305 18F-DCFPyL PSMA PET/CT studies. Each study contained three scans: non-attenuation-corrected PET, attenuation-corrected PET, and low-dose CT. Studies were broken down into three sets for training (185), validation (60) and testing (60). A 2D Pix2Pix generator was then used to generate synthetic attenuation-corrected PET scans (gen-PET) from the original non-attenuation-corrected PET.

For qualitative evaluation, two nuclear medicine physicians reviewed 40 PET/CT studies in a randomized order, blinded to whether the image was from original attenuation-corrected PET or gen-PET. Each expert recorded the number and locations of PET-positive lesions and qualitatively reviewed overall noise and image quality. The readers were able to successfully detect lesions on the gen-PET images with reasonable sensitivity values.

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” said Kevin Ma, PhD, a post-doctoral researcher at the NCI. “This opens opportunities for increasing the frequency and number of PET scans per patient per year, which could provide more accurate assessment for lesion detection, treatment efficacy, radiotracer effectivity, and other measures in research and patient care.”

Related Links:
National Cancer Institute